BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20833513)

  • 1. Proteomic expression analysis of mycosis fungoides (MF) skin tissues: overexpressions of SOD2, S100A8 and FABP5 in MF.
    Liu J; Zeng Y; Zhou Y; Ma D; Wang B
    J Dermatol Sci; 2010 Oct; 60(1):42-4. PubMed ID: 20833513
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides.
    Rasheed H; Tolba Fawzi MM; Abdel-Halim MR; Eissa AM; Mohammed Salem N; Mahfouz S
    Am J Dermatopathol; 2010 Apr; 32(2):162-9. PubMed ID: 20051814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of CXCR3 and CD30 in mycosis fungoides.
    Nikoo A
    Arch Iran Med; 2012 Mar; 15(3):146-50. PubMed ID: 22369302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased progranulin expression in Mycosis fungoides: a possible association with the high frequency of skin infections.
    Nakajima R; Miyagaki T; Kamijo H; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
    Eur J Dermatol; 2018 Dec; 28(6):790-794. PubMed ID: 30530405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides with focal CD 30 transformation in an adolescent.
    Romero M; Haney M; Desantis E; Zlotoff B
    Pediatr Dermatol; 2008; 25(5):565-8. PubMed ID: 18950403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulomatous slack skin: a case of unusual variant of mycosis fungoides.
    Chen M; Qiu B; Kong J
    Chin Med J (Engl); 2000 Feb; 113(2):189-92. PubMed ID: 11775552
    [No Abstract]   [Full Text] [Related]  

  • 8. Bcl-2 expression in mycosis fungoides before and after PUVA therapy.
    Weshahy H; Mahgoub D; El-Eishy N; El-Tawdy AM; Bassiouny DA; Hunter N; Hindawi A
    Photodermatol Photoimmunol Photomed; 2010 Apr; 26(2):107-9. PubMed ID: 20415745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycosis fungoides with spontaneously regressing CD30-positive tumorous lesions.
    Woodrow SL; Basarab T; Russell Jones R
    Clin Exp Dermatol; 1996 Sep; 21(5):370-3. PubMed ID: 9136160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus and activation-regulated chemokine in different stages of mycosis fungoides: tissue and serum levels.
    Abou El-Ela M; El-Rifae Ael-A; Fawzi M; Abdel Hay R; Gohary Y; Shaker O
    Australas J Dermatol; 2011 Aug; 52(3):167-71. PubMed ID: 21834810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human beta-defensins in patients with mycosis fungoides.
    Gambichler T; Skrygan M; Appelhans C; Tomi NS; Reinacher-Schick A; Altmeyer P; Kreuter A
    Arch Dermatol Res; 2007 Jul; 299(4):221-4. PubMed ID: 17415576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.
    Chandra P; Plaza JA; Zuo Z; Diwan AH; Koeppen H; Duvic M; Medeiros LJ; Prieto VG
    Am J Clin Pathol; 2009 Apr; 131(4):511-5. PubMed ID: 19289586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
    Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
    J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fli-1 expression in mycosis fungoides.
    Quick CM; Smoller BR; Hiatt KM
    J Cutan Pathol; 2006 Sep; 33(9):642-5. PubMed ID: 16965340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypopigmented mycosis fungoides in an adolescent Turkish boy.
    Gülekon A; Ozsoy E; Gürer MA; Ataoģlu O
    Int J Dermatol; 2005 Sep; 44(9):795-6. PubMed ID: 16135159
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HECA-452 in parapsoriasis and mycosis fungoides.
    Di Trolio R; Di Lorenzo G; Barbiero E; Iacono A; Franco R; D Armiento M; Delfino M; D Armiento FP
    Int J Immunopathol Pharmacol; 2006; 19(1):105-10. PubMed ID: 16569348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered microRNA expression in mycosis fungoides.
    Maj J; Jankowska-Konsur A; Sadakierska-Chudy A; Noga L; Reich A
    Br J Dermatol; 2012 Feb; 166(2):331-6. PubMed ID: 21966986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.
    Kelemen K; White CR; Gatter K; Braziel RM; Fan G
    Am J Clin Pathol; 2010 Nov; 134(5):739-48. PubMed ID: 20959657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of CD30+ large-cell transformation in a patient with unilesional patch-stage mycosis fungoides.
    Ohtani T; Kikuchi K; Koizumi H; Kunii T; Aiba S
    Int J Dermatol; 2009 Jun; 48(6):623-6. PubMed ID: 19538373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.